Cargando…

ARDS in SARS: cytokine mediators and treatment implications

Detalles Bibliográficos
Autores principales:	Salto-Tellez, Manuel, Tan, Emily, Lim, Bing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2005
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7128468/ https://www.ncbi.nlm.nih.gov/pubmed/15598444 http://dx.doi.org/10.1016/j.cyto.2004.09.002

Ejemplares similares

Use of Spironolactone in SARS-CoV-2 ARDS Patients
por: Dumanlı, Güleren Yartaş, et al.
Publicado: (2020)

Reply: A morpho-molecular prognostic model for hepatocellular carcinoma
por: Srivastava, S, et al.
Publicado: (2013)

Extracorporeal membrane oxygenation for postpneumonectomy ARDS
por: Saueressig, Maurício Guidi, et al.
Publicado: (2014)

Proteomic profiling of lung diffusion impairment in the recovery stage of SARS‐CoV‐2–induced ARDS
por: García‐Hidalgo, María C., et al.
Publicado: (2022)

Potential Role of Anti-Complement Agents in the Treatment of COVID-19-Related ARDS
por: Spanopoulou, Christina, et al.
Publicado: (2020)

Prone positioning in awake non-ICU patients with ARDS caused by COVID-19
por: Taboada, Manuel, et al.
Publicado: (2020)

All Consolidations are not Infective: Look Beyond ARDS
por: Nizami, Mohammed Ismail, et al.
Publicado: (2019)

Transcriptomic evidence of lung repair in paediatric ARDS survival
por: Song, Licheng, et al.
Publicado: (2023)

Transpulmonary pressures in obese and non-obese COVID-19 ARDS
por: Mezidi, Mehdi, et al.
Publicado: (2020)

Fatigue as long-term consequence of ARDS in COVID-19 patients
por: Zuin, Marco, et al.
Publicado: (2021)

Herpesviridae systemic reactivation in patients with COVID-19-associated ARDS
por: Reizine, F., et al.
Publicado: (2022)

Renal failure in COVID-19 ARDS: Could it be partially avoided?
por: Zakynthinos, George E., et al.
Publicado: (2021)

Prolonged low-dose methylprednisolone treatment is highly effective in reducing duration of mechanical ventilation and mortality in patients with ARDS
por: Meduri, Gianfranco Umberto, et al.
Publicado: (2018)

Three cases of ARDS: An emerging complication of Plasmodium vivax malaria - Queries?
por: Zaki, Syed Ahmed
Publicado: (2011)

Post-CPR scrub typhus patient with ARDS: A case report
por: Minhas, Ashish, et al.
Publicado: (2020)

Natural versus artificial light exposure on delirium incidence in ARDS patients
por: Vahedian-Azimi, Amir, et al.
Publicado: (2020)

Herpesviridae reactivation for poor outcome in ARDS patients with ECMO: criminal or witness?
por: Huang, Huixue, et al.
Publicado: (2020)

Ability of the respiratory ECMO survival prediction (RESP) score to predict survival for patients with COVID-19 ARDS and non-COVID-19 ARDS: a single-center retrospective study
por: Pratt, Elias H., et al.
Publicado: (2023)

Evolution of the Human Cytokine Response from Acute Illness to Disease Resolution in SARS-Cov-2 Infection—Implications for Therapeutic Monitoring and Therapeutic Targets
por: Drewett, George P., et al.
Publicado: (2021)

COVID-19 ARDS-related pneumomediastinum and pneumothorax
por: Marwah, Vikas, et al.
Publicado: (2021)

Reverse triggering induced by endotracheal tube leak in lightly sedated ARDS patient
por: Itagaki, Taiga, et al.
Publicado: (2018)

Pulmonary embolism among critically ill patients with ARDS due to COVID-19
por: Soumagne, T., et al.
Publicado: (2020)

Airway opening pressure in an obese ARDS patient: just the start of airway recruitment
por: Katayama, Shinshu, et al.
Publicado: (2023)

Reply to Letter to the Editor: Therapeutic plasma exchange resolving COVID-19 related ARDS
por: Lin, Jui-Hsiang, et al.
Publicado: (2020)

The clinical role of echocardiography in severe COVID-related ARDS: Not just a technical tool
por: Lazzeri, Chiara, et al.
Publicado: (2021)

Letter to the editor: Vitamin D deficiency in critically ill COVID-19 ARDS patients
por: Santos, Maria Eduarda Rodrigues Alves, et al.
Publicado: (2022)

RV dysfunction in Covid-19 ARDS: Is there a difference in the impact of mechanical ventilation and ECMO?
por: Tsolaki, Vasiliki, et al.
Publicado: (2021)

A novel miRNA biomarker panel associated with mortality in pediatric patients with ARDS
por: Lee, Lisa K., et al.
Publicado: (2021)

Steroid treatment for persistent ARDS: a word of caution
por: Thompson, B Taylor, et al.
Publicado: (2007)

Reply to: RV dysfunction in Covid-19 ARDS: Is there a difference in the impact of mechanical ventilation and ECMO?
por: Bleakley, Caroline, et al.
Publicado: (2021)

Reply - Letter to the Editor: Vitamin D deficiency in critically ill COVID-19 ARDS patients
por: Notz, Quirin, et al.
Publicado: (2022)

In Reply — Neutralization of Fecal Aerosol-Laden SARS CoV-2: Public Health Implications
por: McDermott, Carmen V., et al.
Publicado: (2021)

Could ruxolitinib be effective in patients with COVID-19 infection at risk of acute respiratory distress syndrome (ARDS)?
por: Caocci, Giovanni, et al.
Publicado: (2020)

COVID-19, acute respiratory distress syndrome (ARDS), and hyperbaric oxygen therapy (HBOT): what is the link?
por: De Maio, Antonio, et al.
Publicado: (2020)

Oxygenation Efforts for Iranian COVID-19 ARDS Patients: First 5-Day Crisis Experience Scenario
por: Hashemian, Seyed Mohammadreza, et al.
Publicado: (2020)

Is it time to revisit the PaO(2)/FiO(2) ratio to define the severity of oxygenation in ARDS?
por: Palanidurai, Sunitha, et al.
Publicado: (2021)

Incorporating ventilatory support parameters into the PaO(2)/FiO(2) ratio in ARDS patients
por: El-Khatib, Mohamad F., et al.
Publicado: (2021)

AIP or ARDS? Not just semantics
por: Singh, Navneet
Publicado: (2006)

AVDS should not dethrone ARDS
por: Mahjoub, Yazine, et al.
Publicado: (2021)

Comment on “Respiratory mechanics and gas exchanges in the early course of COVID-19 ARDS: a hypothesis-generating study”
por: Damiani, Elisa, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_oii4rss9jdai5iv3v8bs3h3pom